Published in

Elsevier, International Journal of Cardiology, 3(168), p. 2186-2194, 2013

DOI: 10.1016/j.ijcard.2013.01.228

Links

Tools

Export citation

Search in Google Scholar

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

Journal article published in 2013 by Johan Lassus, Christian Mueller, W. Frank Peacock, Jindrich Spinar, Etienne Gayat, Roland van Kimmenade, Atul Pathak, Thomas Mueller, Veli-Pekka Harjola, Salvatore diSomma, Marco Metra ORCID, Domingo Pascual-Figal, Damien Logeart, Semir Nouira, Said Laribi and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Aim: This study aims to evaluate the incremental value of plasma biomarkers to traditional clinical variables for risk stratification of 30-day and one-year mortality in acutely decompensated heart failure (ADHF). Methods and results: Through an international collaborative network, individual patient data on 5306 patients hospitalized for ADHF were collected. The all-cause mortality rate was 11.7% at 30 days and 32.9% at one year. The clinical prediction model (age, gender, blood pressure on admission, estimated glomerular filtration rate